Christine S. Wilson

Wilson has long been involved in Republican Party politics. Wilson donated $2,700 to Ted Cruz's presidential campaign in 2016^[2] and $2,500 to Cruz's Senate campaign in 2011. During the 2008 presidential campaign, Wilson served on the antitrust committee that advised John McCain's presidential campaign.^[3]

In 2018, President Donald Trump selected Wilson to serve as a member of the FTC, and she assumed office later that year.^[7] In a February 2023 piece in the Wall Street Journal, Wilson announced her resignation from the FTC, citing her opposition to chair Lina Khan's leadership of the agency and Khan's refusal to recuse from a FTC lawsuit to block Meta's acquisition of a virtual reality app maker.^[8]

While working as a staffer on the House Judiciary Committee, Khan helped author a report whose "findings and recommendations clearly show[ed] that it is long-past time for Congress to enact meaningful updates to our antitrust laws to address the lack of competition in digital markets and the monopoly power," of tech firms.^[9][10] Wilson's resignation became effective on March 31, 2023.^[11]

After her resignation, commentators reported that while at the FTC, Wilson voted to approve a $74-billion pharmaceutical merger between Bristol-Myers and Celgene.^[12] Wilson had represented Bristol-Myers while an antitrust partner at Kirkland & Ellis.^{[13][14][15][1]}